{"DataElement":{"publicId":"6617383","version":"1","preferredName":"Malignant Neoplasm Fludeoxyglucose F 18 Positron Emission Tomography Uptake Assessment Finding Lesion Soft Tissue Uptake","preferredDefinition":"Status of FDG-PET uptake for soft tissue lesion","longName":"SFTS_LSN_FDG_PET_UPTAKE_ST","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3871876","version":"1","preferredName":"Malignant Neoplasm Fludeoxyglucose F 18 Positron Emission Tomography Uptake Assessment Finding","preferredDefinition":"information related to the uptake or abosorbtion of Fludeoxyglucose F 18 (FDG), the radioactive form of glucose used in positron emission tomography (PET) assessment, of a malignant neoplasm, a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.","longName":"LsnFDGPETUptake","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3871874","version":"1","preferredName":"Fludeoxyglucose F 18 Positron Emission Tomography Uptake Assessment Finding","preferredDefinition":"The radioactive form of glucose used in positron emission tomography (PET), a diagnostic imaging procedure.:A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.:The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.:Having determined the value, significance, or extent of.:Clinical, laboratory or molecular evidence, or absence of evidence of disease. ","longName":"3871874v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fludeoxyglucose F-18","conceptCode":"C964","definition":"A positron-emitting radiopharmaceutical containing radioactive 2-deoxy-2-[18F] fluoro-D-glucose. With similar cell uptake as glucose (high in tumor cells), fludeoxyglucose F 18 is not dephosphorylated and further metabolized. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Uptake","conceptCode":"C71688","definition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5328507-4DD8-E213-E040-BB89AD434BBE","latestVersionIndicator":"Yes","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"ONEDATA","dateModified":"2013-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5328507-4DE9-E213-E040-BB89AD434BBE","latestVersionIndicator":"Yes","beginDate":"2013-08-30","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-08-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6617376","version":"1","preferredName":"Lesion Soft Tissue Uptake Uptake Status","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Lacking in hardness relatively or comparatively._An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function._The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention._The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention._A condition or state at a particular time.","longName":"6617376v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"FDG PET uptake resolved","valueDescription":"Uptake Resolution FDG-Positron Emission Tomography","ValueMeaning":{"publicId":"6617377","version":"1","preferredName":"Uptake Resolution FDG-Positron Emission Tomography","longName":"6617377","preferredDefinition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.: A means of finding a solution to a problem, or a means of finding agreement or harmony.: An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uptake","conceptCode":"C71688","definition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Resolution","conceptCode":"C75906","definition":"A means of finding a solution to a problem, or a means of finding agreement or harmony.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"FDG-Positron Emission Tomography","conceptCode":"C103400","definition":"An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAB7331-3BEB-33A2-E053-F662850AAB3C","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FAB7331-3C04-33A2-E053-F662850AAB3C","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","deletedIndicator":"No"},{"value":"FDG-PET uptake improved","valueDescription":"Uptake Improved FDG-Positron Emission Tomography","ValueMeaning":{"publicId":"6617378","version":"1","preferredName":"Uptake Improved FDG-Positron Emission Tomography","longName":"6617378","preferredDefinition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.: A subjective response indicating that something improved.: An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uptake","conceptCode":"C71688","definition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Improved","conceptCode":"C125459","definition":"A subjective response indicating that something improved.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"FDG-Positron Emission Tomography","conceptCode":"C103400","definition":"An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAB7331-3C12-33A2-E053-F662850AAB3C","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FAB7331-3C2B-33A2-E053-F662850AAB3C","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","deletedIndicator":"No"},{"value":"FDG-PET uptake stable","valueDescription":"Uptake Stable FDG-Positron Emission Tomography","ValueMeaning":{"publicId":"6617379","version":"1","preferredName":"Uptake Stable FDG-Positron Emission Tomography","longName":"6617379","preferredDefinition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.: Subject to little fluctuation; showing little if any change.: An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uptake","conceptCode":"C71688","definition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stable","conceptCode":"C30103","definition":"Subject to little fluctuation; showing little if any change.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"FDG-Positron Emission Tomography","conceptCode":"C103400","definition":"An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAB7331-3C39-33A2-E053-F662850AAB3C","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FAB7331-3C52-33A2-E053-F662850AAB3C","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","deletedIndicator":"No"},{"value":"New lesion that is FDG-PET avid","valueDescription":"Lesion Positron Emission Tomography New","ValueMeaning":{"publicId":"7755261","version":"1","preferredName":"Lesion Positron Emission Tomography New","longName":"7755261","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.: A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.: Having no previous example or precedent or parallel; of a kind not seen before.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C8848D98-5BD6-25FD-E053-4EBD850A4A3F","latestVersionIndicator":"Yes","beginDate":"2021-08-01","endDate":null,"createdBy":"LAMEMIL","dateCreated":"2021-08-01","modifiedBy":"ONEDATA","dateModified":"2021-08-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C8848D98-5BEF-25FD-E053-4EBD850A4A3F","beginDate":"2021-08-01","endDate":null,"createdBy":"LAMEMIL","dateCreated":"2021-08-01","modifiedBy":"ONEDATA","dateModified":"2021-08-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6617384","version":"1","preferredName":"Lesion Soft Tissue Uptake Status","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.:Lacking in hardness relatively or comparatively.:An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.:The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.:A condition or state at a particular time.","longName":"6617384v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Soft","conceptCode":"C25255","definition":"Lacking in hardness relatively or comparatively.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Uptake","conceptCode":"C71688","definition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAB9DDF-CB60-1088-E053-F662850AC397","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAB7331-3BD2-33A2-E053-F662850AAB3C","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"LAMEMIL","dateModified":"2021-09-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If Yes, specify:","type":"Preferred Question Text","description":"If Yes, specify:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAB7331-3C5E-33A2-E053-F662850AAB3C","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"PROSVIROVAB","dateModified":"2019-06-11","changeDescription":"Curated for ANBL1821","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}